Pharmaceutical composition for oral administration

Details for Australian Patent Application No. 2009300751 (hide)

Owner Astellas Pharma Inc.

Inventors Oba, Shinsuke; Yasuji, Takehiko; Hakomori, Tadashi; Sako, Kazuhiro

Agent Davies Collison Cave

Pub. Number AU-A-2009300751

PCT Pub. Number WO2010/038689

Priority 61/101,356 30.09.08 US

Filing date 28 September 2009

Wipo publication date 8 April 2010

International Classifications

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/038689 Priority application(s): WO2010/038689

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009300752-Controlled release pharmaceutical composition

2009300749-Manufacturing method of absorbent article